DEF 14AThe Ballot
Niagen Bioscience, Inc. files DEF 14A
Filed Apr 23, 2019 · 7y ago · Accession 0001654954-19-004691
Plain English
Proxy statement — executive pay, board nominees, and shareholder votes.
Read the source below for the full document.
Filing details
- Company
- Niagen Bioscience, Inc.
- Ticker
- NAGE
- CIK
- 1386570
- Form type
- DEF 14A
- Filing date
- Apr 23, 2019
- Report date
- Jun 21, 2019
- Document
- cdxcdef14a_06212019.htm
- Size
- 728 KB